Lacoptal 50mg Tablet contains lacosamide, an antiepileptic agent indicated for the treatment of partial-onset seizures in patients with epilepsy. Lacosamide acts by selectively enhancing slow inactivation of voltage-gated sodium channels, stabilizing hyperexcitable neuronal membranes and inhibiting repetitive neuronal firing without affecting normal neuronal excitability. This mechanism contributes to its efficacy in reducing seizure frequency. Lacoptal is typically administered orally, with dosing individualized based on clinical response and tolerability. It may be used as monotherapy or adjunctive therapy in adults and pediatric patients aged 4 years and older. The pharmacokinetic profile of lacosamide demonstrates rapid absorption, linear kinetics, and minimal drug-drug interactions, making it suitable for combination with other antiepileptic drugs. Common adverse effects include dizziness, headache, nausea, and diplopia, though it is generally well tolerated. Caution is advised in patients with cardiac conduction abnormalities due to potential PR interval prolongation. Regular monitoring of cardiac function and seizure control is recommended during treatment. Lacoptal 50mg Tablet provides an effective and well-tolerated option for managing partial-onset seizures, contributing to improved patient quality of life when used under appropriate medical supervision.